Added to YB: 2025-10-08
Pitch date: 2025-08-21
AMRN [bullish]
Amarin Corporation plc
-9.29%
current return
Author Info
No bio for this author
Company Info
Amarin Corporation plc, a pharmaceutical company, engages in the commercialization and development of therapeutics for the treatment of cardiovascular diseases in the United States, Europe, and internationally.
Market Cap
$389.7M
Pitch Price
$15.83
Price Target
47.50 (+231%)
Dividend
N/A
EV/EBITDA
-2.22
P/E
-3.75
EV/Sales
0.46
Sector
Biotechnology
Category
value
Amarin Corporation plc - $AMRN
AMRN: Asset-lite royalty play post-Recordati partnership. $300M net cash (100% of market cap) + potential $20M-$40M annual royalty income from UK/EU sales at 20% take rate. RoW partnerships add $15M income. US biz generates $50M cash. Patent protected until 2039. Potential 2x-3x upside vs limited downside risk.
Read full article (7 min)